[3-(3-nitrophenyl)-1,2,4-oxadiazol-5-yl]methanamine, 95.0%, 2g

7-(4-(tert-Butyl)benzyl)-1,3-dimethyl-1H-purine-2,6(3H,7H)-dione, 95%, 50mg

Recipientes para muestras Cubeta para muestras con cierre de rosca, estéril, 200 Unidad(es)

5-(4-Bromophenyl)-4-chlorothieno[2,3-d]pyrimidine, 97%, 1g

5-Benzylimidazolidine-2,4-dione, 97%, 500mg

BENZBROMARONE, 95%, 1g

tert-Butyl 5-oxo-5,7-dihydrospiro[cyclopenta[b]pyridine-6,4'-piperidine]-1'-carboxylate, 97%, 25g

1,3-Dioxo-2,3-dihydro-1h-isoindol-2-yl cyclohexanecarboxylate, 97%, 5g

1H-INDAZOLE-4,7-DIAMINE, 95%, 250mg

2-(2-Chlorophenyl)piperazine dihydrochloride, 100mg

6-Methoxy-2-oxo-1,2-dihydropyridine-3-carboxylic acid, 97.0%, 1g

5-Aminopyrimidine-2-carboxamide, 95.0%, 5g

1-ethyltricyclo[2.2.1.0~2,6~]heptan-3-one, 95.0%, 1g